Matches in Nanopublications for { ?s ?p "DDI between Trimipramine and Maprotiline - Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome. Additive QTc-prolongation may also occur, increasing the risk of serious ventricular arrhythmias. Concomitant therapy should be used with caution. [drugbank_resource:DB00726_DB00934]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00726_DB00934 label "DDI between Trimipramine and Maprotiline - Increased risk of serotonin syndrome. Monitor for symptoms of serotonin syndrome. Additive QTc-prolongation may also occur, increasing the risk of serious ventricular arrhythmias. Concomitant therapy should be used with caution. [drugbank_resource:DB00726_DB00934]" assertion.